Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/12/06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
13 | |
| 05/10/06 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 03/30/06 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
37 | |
| 01/18/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/18/06 | 3/A | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/09/05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
13 | |
| 10/27/05 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 10/27/05 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 10/27/05 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 10/27/05 | 3 | Initial statement of beneficial ownership of securities |
|
1 |
